You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Titer Antibodies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dengue Trial in Mexico city (Estimate the distribution of antibodies by serotype by Dengue virus in areas of low and high

Not yet recruiting
  • Dengue
  • Estimate the distribution of antibodies by serotype by Dengue virus in areas of low and high incidence of dengue
  • Mexico city, Mexico
    Mexican Society of Public Health
Mar 2, 2022

Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)

Not yet recruiting
  • Hemophilia A With Inhibitor
  • SCT800 and Daratumumab
  • (no location specified)
May 24, 2023

Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in

Recruiting
  • SARS-CoV2 Infection
  • SARS-CoV2 Antibodies
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
  • Bydgoszcz, Poland
    Department of Transplantology and General Surgery, Dr. A. Jurasz
Dec 15, 2021

Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study

Active, not recruiting
  • SARS-CoV2 Infection
  • SARS-CoV2 Antibodies
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
  • Bydgoszcz, Kujawsko-Pomorskie, Poland
    Cardiology Department, Dr. A. Jurasz University Hospital
Nov 4, 2021

COVID-19 Trial in Milwaukee (anti-SARS-CoV-2 convalescent plasma)

Completed
  • COVID-19
  • anti-SARS-CoV-2 convalescent plasma
  • Milwaukee, Wisconsin
    Froedtert Hospital
Aug 23, 2022

COVID-19 Trial in Chapel Hill (High-titer Convalescent COVID-19 Plasma (CCP1), Standard-titer Convalescent COVID-19 plasma

Completed
Has Results
  • COVID-19
  • High-titer Convalescent COVID-19 Plasma (CCP1)
  • Standard-titer Convalescent COVID-19 plasma (CCP2)
  • Chapel Hill, North Carolina
    University of North Carolina Health Care
Dec 1, 2021

Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)

Completed
  • Renal Transplant
  • Seoul, Korea, Republic of
  • +1 more
Oct 25, 2022

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

Recruiting
  • Immunocompromised Patients
  • Data collection
  • Paris, Ile De France, France
    Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022

COVID Trial in Stony Brook (Convalescent Plasma, Standard Donor Plasma)

Terminated
Has Results
  • COVID
  • Convalescent Plasma
  • Standard Donor Plasma
  • Stony Brook, New York
    Stony Brook University Hospital
Dec 2, 2021

COVID, Infectious Disease Trial in Boston (High-Titer COVID-19 Convalescent Plasma (HT-CCP), Standard Plasma (FFP))

Terminated
  • COVID
  • Infectious Disease
  • High-Titer COVID-19 Convalescent Plasma (HT-CCP)
  • Standard Plasma (FFP)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Aug 9, 2021

SARS-CoV2 Infection, SARS-CoV-2 Acute Respiratory Disease, Myeloma Trial in London (BMS-986414, BMS-986413)

Withdrawn
  • SARS-CoV2 Infection
  • +6 more
  • BMS-986414
  • BMS-986413
  • London, United Kingdom
    Imperial College Heathcare NHS Trust
May 24, 2022

Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine Trial in Taipei (recombinant hepatitis B vaccine)

Recruiting
  • Hepatitis B
  • +2 more
  • recombinant hepatitis B vaccine
  • Taipei, Taiwan
    Family Medicine, NTUH
Jun 24, 2022

Plasma From People Who Recovered From or Were Vaccinated to

Enrolling by invitation
  • Communicable Diseases
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 27, 2022

    Schizophrenia, Gluten Sensitivity, Schizo Affective Disorder Trial in Catonsville (Gluten Flour in Protein Shake, Rice Flour in

    Recruiting
    • Schizophrenia
    • +2 more
    • Gluten Flour in Protein Shake
    • Rice Flour in Protein Shake
    • Catonsville, Maryland
      Maryland Psychiatric Research Center (MPRC) Outpatient Research
    Oct 28, 2021

    Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

    Not yet recruiting
    • Ebola Virus Disease
    • N'Zerekore, Guinea
      Centre de Traitement Ebola de N'Zerekore
    Oct 14, 2021

    COVID-19 Trial in United States (casirivimab+imdevimab)

    Active, not recruiting
    • COVID-19
    • Anaheim, California
    • +6 more
    Jan 26, 2022

    Allosensitization, Heart Transplant Failure and Rejection Trial in Stanford (Daratumumab-SC)

    Recruiting
    • Allosensitization
    • Heart Transplant Failure and Rejection
    • Stanford, California
      Stanford Health Care
    Sep 20, 2021

    Hemophilia A or B With Inhibitors, Hemophilia A, Hemophilia B Trial in Worldwide (Factor VIII Inhibitor Bypassing Activity

    Completed
    Has Results
    • Hemophilia A or B With Inhibitors
    • +2 more
    • Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
    • Chicago, Illinois
    • +16 more
    Apr 29, 2021

    COVID-19 Trial in United States (casirivimab+imdevimab)

    Recruiting
    • COVID-19
    • Anaheim, California
    • +5 more
    Dec 6, 2021

    Pulmonary Hypertension in Patients Attending Sohag University

    Recruiting
    • Patients With Pulmonary Hypertension
    • echocardiography
    • Sohag, Egypt
      Sohag University Hospital
    Jan 12, 2022

    Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

    Not yet recruiting
    • Antibody-mediated Rejection
    • Allosensitization
    • New York, New York
      NYU Langone Health
    May 16, 2023

    AVB - Atrioventricular Block, Fetal AVB Trial in Canada, United States (Dexamethasone, IVIG)

    Recruiting
    • AVB - Atrioventricular Block
    • Fetal AVB
    • Phoenix, Arizona
    • +35 more
    Jan 11, 2022

    Hemorrhagic Shock, Trauma Injury Trial (Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA))

    Not yet recruiting
    • Hemorrhagic Shock
    • Trauma Injury
    • Low Titer Group O Whole Blood (LTOWB)
    • +3 more
    • (no location specified)
    Oct 9, 2023

    Acute Kidney Injury Trial in Baltimore (Digoxin Antibodies Fab Fragments, Placebo)

    Recruiting
    • Acute Kidney Injury
    • Digoxin Antibodies Fab Fragments
    • Placebo
    • Baltimore, Maryland
    • +1 more
    Dec 15, 2021